MSMG
Election Coverage | 2026 Live
← Back to News
Dow Up, Baird Medical Investments Holdings Up

Dow Up, Baird Medical Investments Holdings Up

finance • 2026-03-04

Baird Medical Investment Holdings shares rose 0.95 points to end the day at $3.44 per share.

All three major indices rose today.

The NASDAQ rose 290.79 ponts.

The DOW rose 238.14 points.

The S&P 52.87 points.

The markets clawed back from Monday and Tuesday's debilitating losses. Stabilized oil prices motivaTED today's market recovery. The market moderated after days of surging energy costs tied to the escalating US-Iran conflict and disruptions in the Middle East. Treasury Secretary Scott Bessent also helped calm the waters by signaling upcoming measures to ease fuel prices. As investors reassessed the immediate magnitude of these economic risks, tech shares and insurers bounced back from their recent slumps, with companies like Amazon, AMD, and Micron posting solid gains. This U.S. rebound was especially notable given the turbulent global backdrop earlier in the day, which saw South Korea's Kospi index plunge a historic 12.1 percent.

All this as Baird Medical Investments Holdings shares rose 0.95 points to end the day at $3.44 per share. Founded in 2012 and headquartered in Guangzhou, China, the medical device manufacturer specializes in minimally invasive microwave ablation technology. Their devices are primarily used to treat benign and malignant tumors, making them a recognized market leader in China for thyroid ablation devices.

The company's stock price surged after they announced the successful development of a new cross-platform AI surgical software and has initiated the regulatory registration process across the United States, the European Union, and China. This new platform utilizes an artificial intelligence model to automate clinical workflows, including anatomical mapping, treatment planning, and procedural simulations. Ultimately, it is designed to integrate seamlessly with the company's planned automated surgical robotic system. The market reacted enthusiastically to the news, sending the stock surging roughly 25 to 30 percent today. While Baird Medical operates with an impressive gross profit margin of around 87 percent, the company currently remains unprofitable on a net income basis as it pushes for aggressive global expansion.